Market Tracker

06/29 5:16pm ET

Bristol-Myers Squibb Co (NYSE:BMY)

73.00
Delayed Data
As of Jun 29
 +0.99 / +1.37%
Today’s Change
51.82
Today|||52-Week Range
75.12
+6.12%
Year-to-Date
BMY Regular Dividend: BMY began trading ex-dividend on 06/29/16. A $0.38 dividend will be paid to shareholders of record as of 07/01/16.
These Large Pharmaceutical Stocks Should be on your Radar
Jun 29 / Zacks.com - Paid Partner Content
Infinity Regains Duvelisib Rights, Announces Restructuring
Jun 29 / Zacks.com - Paid Partner Content
McKesson's IT Business to Merge with Change Healthcare
Jun 29 / Zacks.com - Paid Partner Content
Endo's Stock Gains on Vasostrict's New Patent Approval
Jun 29 / Zacks.com - Paid Partner Content
Roche's Multiple Sclerosis Drug Under Review by FDA, EMA
Jun 29 / Zacks.com - Paid Partner Content
Pfizer Investing $350M in China, Setting up Biotech Center
Jun 28 / Zacks.com - Paid Partner Content
How Pfizer, Merck May Feel Long-term Pinch From Brexit
Jun 29 / TheStreet.com - Paid Partner Content
5 Medical Stocks to Buy with Great Dividend Yields
Jun 28 / Zacks.com - Paid Partner Content
Esperion (ESPR) Offers Updates on LDL-Lowering Candidate
Jun 29 / Zacks.com - Paid Partner Content
Cramer: Here's What's Behind the Horrible Politics of Brexit
Jun 28 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close72.01
Today’s open72.12
Day’s range71.96 - 73.17
Volume6,539,785
Average volume (3 months)6,095,917
Market cap$120.2B
Dividend yield2.08%
Data as of 4:00pm ET, 06/29/2016

Growth & Valuation

Earnings growth (last year)-22.50%
Earnings growth (this year)+25.84%
Earnings growth (next 5 years)+21.20%
Revenue growth (last year)+4.29%
P/E ratio77.9
Price/Sales6.97
Price/Book8.38

Competitors

 Today’s
change
Today’s
% change
SNYSanofi+0.71+1.75%
NVONovo Nordisk+0.78+1.49%
GSKGlaxoSmithKline+1.13+2.73%
ABBVAbbVie+1.82+3.03%
Data as of 4:02pm ET, 06/29/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$0.66
Annual revenue (last year)$16.6B
Annual profit (last year)$1.6B
Net profit margin9.45%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Giovanni Caforio
Chief Financial Officer &
Executive Vice President
Charles A. Bancroft
Corporate headquarters
New York, New York

Forecasts